Papers: 10.1371/journal.pone.0200923

https://doi.org/10.1371/journal.pone.0200923

Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML)

Cited by: 14
Author(s): Melanie Gentil, Patricia Hugues, Christophe Desterke, Gladys Telliam, Ivan Sloma, Lucas Eduardo Botelho de Souza, Seda Baykal, Jérôme Artus, Frank Griscelli, Agnès Guerci, Hyacinthe Johnson‐Ansah, Adlen Foudi, Annelise Bennaceur-Griscelli, Ali G. Turhan
Published: almost 7 years ago

Software Mentions 1